Innovators in comprehensive urological care
Urology of Virginia has provided comprehensive urological care in Hampton Roads for nearly 100 years. Founded in 1922 by Charles Devine, the practice began growing in the 1950s. The practice gained an international reputation for genitourinary reconstructive surgery, developing new surgical techniques to correct urethral strictures and hypospadias that are still used today. In 1965, Urology of Virginia became one of the few private practices in the country to have a residency program. In the 1970s, we were instrumental in helping establish Eastern Virginia Medical School, Norfolk, Virginia, serving as faculty and becoming one of the first established EVMS departments.
We are here to help you in anyway. Feel free to click the button below to see contact options.
Contact Us Now!
Lower PSA and shorter PSA doubling times prior to salvage radiotherapy (RT) for prostate cancer after primary radical prostatectomy are associated with favorable biochemical...
12/01/2021
Among men with palpable prostate cancer (PCa) and normal-range PSA level at diagnosis, the risk of cancer-related death increases as PSA level decreases, a new study...
11/30/2021
Salvage radiation therapy (SRT) given after radical prostatectomy may improve outcomes in prostate cancer (PCa) patients, even in those who fail the treatment, according to...
11/30/2021
Sleep disorders (SDs) are associated with an increased risk of both nocturia and daytime lower urinary tract symptoms (LUTS), according to a new study. The study, by Richard...
11/30/2021
(HealthDay News) -- For women with urinary tract infections (UTIs), the most frequently prescribed antibiotics during the first trimester are nitrofurantoin, ciprofloxacin,...
11/30/2021
Women with uncomplicated lower urinary tract infections (UTIs) experience greater clinical and microbiologic resolution with nitrofurantoin than fosfomycin, according to a new...
11/30/2021
SAN FRANCISCO—Testosterone replacement therapy (TRT) for men with a history of prostate cancer (PCa) does not increase recurrence rates following radical treatment or...
11/29/2021
A non-invasive urinary test for telomerase reverse transcriptase (TERT) promoter mutations may identify recurrent urothelial bladder cancer (UBC) earlier than standard cytology...
11/29/2021
(HealthDay News) — The risk of arterial thromboembolism is increased in the short term among patients with incident cancer, according to a study published in the Journal of the...
11/29/2021
The FDA has accepted a supplemental New Drug Application (NDA) for Cysview (hexaminoluvinate HCl) on a priority review basis. Photocure, the Oslo, Norway-based company that...
11/29/2021
In keeping with postmarketing experience, a new study finds a slight increase in the risks of self-harm and depression among users of 5 alpha-reductase inhibitors...
11/29/2021
Use of prescription non-steroid anti-inflammatory drugs (NSAIDs) is associated with an increased risk of benign prostatic hyperplasia (BPH), according to study findings...
11/28/2021